San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Epstein Family Foundation Awards $1 Million to Research Institute

The Epstein Family Foundation has granted Sanford Burnham Prebys Medical Discovery Institute $1 million to pursue pancreatic and prostate cancer research.

PatientSafe Solutions Raises Nearly $4.5 Million in Financing Round

PatientSafe Solutions Inc. this month reported selling nearly $4.5 million in notes convertible to preferred stock in the San Diego-based health-care information technology company.

Vincent Aurentz Joins Arena Pharmaceuticals

San Diego drugmaker Arena Pharmaceuticals Inc. announced that Vincent Aurentz is joining the company as executive vice president and chief business officer, effective today.

Jerome Zeldis Named CMO at Sorrento Therapeutics

The former chief medical officer of pharmaceutical giant Celgene Corp., Dr. Jerome Zeldis, is joining San Diego’s Sorrento Therapeutics Inc. as its new chief medical officer and president of clinical development.

Tease photo

Faheem Hasnain Joins Board of Vital Therapies

Faheem Hasnain, a well-respected biotech executive, has been appointed to Vital Therapies Inc.’s board of directors.

Connect Is Seeking Life Science Startups for Investment Program CapitalMatch

San Diego’s early-stage life science companies are invited to apply for CapitalMatch, a program run by San Diego startup accelerator Connect to link companies seeking funding with interested investors.

Prosecutors Charge Two S.D. Businessmen With Insider Trading in Biotech Case

Federal prosecutors have charged two San Diego businessmen with insider trading for using a confidential tip to snag $83,000 in profit when local biotech Ardea Biosciences was acquired in 2012.

Halozyme Increases Estimate for Yearly Net Revenue

Halozyme Therapeutics Inc. bumped its estimate for this year’s total net revenue haul to a high of $150 million, according to a recent financial statement.

Biocept Inc. Signs Distribution Deal for Philippines

Biocept Inc. struck a deal with life science distributor HarlePhil Venture Inc. to get Biocept’s liquid biopsy tests into the Philippines market.

Kura Oncology Reports Results of Cancer Drug's Phase 2 Trial

Kura Oncology stock is trading sharply higher this morning after revealing the results of a Phase 2 trial of one of its cancer drugs, Tipifarnib.

Illumina Strikes Deal With Oregon-Based Tech Firm FlowJo

Medtech giant Illumina Inc. announced a partnership with Oregon-based tech firm FlowJo LLC to develop and co-market software for analyzing single-cell, next-generation sequencing data.

Acadia Pharmaceuticals Looking to Raise $200 Million

San Diego drugmaker Acadia Pharmaceuticals Inc. is looking to raise $200 million in a secondary offering.

Scintilla Pharmaceuticals Acquires Pennsylvania Company

Scintilla Pharmaceuticals Inc., a subsidiary of San Diego’s Sorrento Therapeutics Inc., is acquiring a Pennsylvania-based pharmaceutical company focused on pain management.

MEI Pharma Inks Deal Potentially Worth Nearly a Half-Billion Dollars

San Diego biotech MEI Pharma signed a major deal with Swiss pharmaceutical group Helsinn that could be worth up to $464 million.

Orexigen Reports Second Quarter Results

San Diego’s Orexigen Therapeutics Inc. reported a jump in quarterly revenue, but missed Wall Street’s expectations for total earnings-per-share, according to a recent earnings statement.